BIOLASE INC Reports Second Quarter Financial Results
BIOLASE, INC. Reports Second Quarter Financial Results
Overview and Financial Metrics
BIOLASE, Inc. reported its financial results for the quarter ended June 30, 2024.
Financial Metric | Q2 2024 | Q2 2023 | YoY Change | Consensus Estimate | Difference |
---|---|---|---|---|---|
Total Revenue | $11.6 million | $14.3 million | -19% | $13.49 million | -$1.89 million |
Earnings Per Share (EPS) | -$2.80 million | -$4.9 million | Improved | -$0.07 | N/A |
BIOLASE’s financial performance for Q2 2024 saw a revenue of $11.6 million, a decrease of 19% from the same period last year. The year-over-year decline in revenue was primarily attributed to the impact of the macroeconomic environment, including increased interest rates leading to extended sales cycles. The company’s EPS improved but still showed a net loss of $2.80 million.
Revenue Performance Across Segments
Segment | Q2 2024 Revenue | Q2 2023 Revenue | YoY Change (%) |
---|---|---|---|
Laser Systems | 52% of total | N/A | N/A |
Consumables | 48% of total | N/A | N/A |
BIOLASE’s revenue segments include laser systems and consumables/accessories. For Q2 2024, laser systems accounted for 52% of total revenue, while consumables and other services made up 48%.
The decrease in overall revenue was primarily driven by lower sales of laser systems, attributed to the challenging economic environment, which resulted in longer sales cycles.
Conclusion
BIOLASE, Inc. reported a challenging quarter, with significant revenue decline and a net loss, though somewhat mitigated year-over-year. The company highlighted the impact of macroeconomic conditions, particularly higher interest rates, which contributed to extended sales cycles and reduced laser system revenues.
Note: The sections "Key Operational Data," "Comments from Company Officers," "Dividends or Share Repurchase Program," "Forward Guidance," and "Stock Price Movement" were removed as they did not contain useful information for investors.
Share